NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TrustCo Bank Corp NY TRST, Actua Corporation ACTA, Cara Therapeutics, Inc. CARA, Cabot Oil & Gas Corporation COG, Astronics Corporation ATRO, and Central Garden & Pet Company CENTA, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
TRST DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRST
ACTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACTA
CARA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CARA
COG DOWNLOAD: http://Fundamental-Markets.com/register/?so=COG
ATRO DOWNLOAD: http://Fundamental-Markets.com/register/?so=ATRO
CENTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CENTA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine TrustCo Bank Corp NY TRST, Actua Corporation ACTA, Cara Therapeutics, Inc. CARA, Cabot Oil & Gas Corporation COG, Astronics Corporation ATRO, and Central Garden & Pet Company CENTA on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
TRUSTCO BANK CORP NY (TRST) REPORT OVERVIEW
TrustCo Bank Corp NY's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, TrustCo Bank Corp NY reported interest income of $42.79MM vs $40.50MM (up 5.64%) and basic earnings per share $0.13 vs $0.11 (up 14.91%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, TrustCo Bank Corp NY reported interest income of $161.36MM vs $159.35MM (up 1.26%) and basic earnings per share $0.45 vs $0.44 (up 0.45%). TrustCo Bank Corp NY is expected to report earnings on January 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017.
To read the full TrustCo Bank Corp NY (TRST) report, download it here: http://Fundamental-Markets.com/register/?so=TRST
-----------------------------------------
ACTUA CORPORATION (ACTA) REPORT OVERVIEW
Actua's Recent Financial Performance
For the twelve months ended December 31st, 2016 vs December 31st, 2015, Actua reported revenue of $109.30MM vs $98.43MM (up 11.04%) and basic earnings per share $1.91 vs -$2.59. Actua is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is -$0.95 and is expected to report on March 8th, 2018.
To read the full Actua Corporation (ACTA) report, download it here: http://Fundamental-Markets.com/register/?so=ACTA
-----------------------------------------
CARA THERAPEUTICS, INC. (CARA) REPORT OVERVIEW
Cara Therapeutics' Recent Financial Performance
For the twelve months ended December 31st, 2016 vs December 31st, 2015, Cara Therapeutics reported revenue of $0.09MM vs $3.80MM (down 97.74%) and basic earnings per share -$2.10 vs -$1.00. Cara Therapeutics is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.81. The estimated EPS forecast for the next fiscal year is -$1.82 and is expected to report on March 8th, 2018.
To read the full Cara Therapeutics, Inc. (CARA) report, download it here: http://Fundamental-Markets.com/register/?so=CARA
-----------------------------------------
CABOT OIL & GAS CORPORATION (COG) REPORT OVERVIEW
Cabot Oil & Gas' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Cabot Oil & Gas reported revenue of $385.42MM vs $310.43MM (up 24.16%) and basic earnings per share $0.04 vs -$0.02. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Cabot Oil & Gas reported revenue of $1,155.68MM vs $1,357.15MM (down 14.85%) and basic earnings per share -$0.91 vs -$0.28. Cabot Oil & Gas is expected to report earnings on February 23rd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.01. The estimated EPS forecast for the next fiscal year is $1.04 and is expected to report on February 23rd, 2018.
To read the full Cabot Oil & Gas Corporation (COG) report, download it here: http://Fundamental-Markets.com/register/?so=COG
-----------------------------------------
ASTRONICS CORPORATION (ATRO) REPORT OVERVIEW
Astronics' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Astronics reported revenue of $149.64MM vs $155.10MM (down 3.52%) and basic earnings per share $0.21 vs $0.42 (down 50.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Astronics reported revenue of $633.12MM vs $692.28MM (down 8.55%) and basic earnings per share $1.66 vs $2.29 (down 27.51%). Astronics is expected to report earnings on February 16th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $2.06 and is expected to report on February 16th, 2018.
To read the full Astronics Corporation (ATRO) report, download it here: http://Fundamental-Markets.com/register/?so=ATRO
-----------------------------------------
CENTRAL GARDEN & PET COMPANY (CENTA) REPORT OVERVIEW
Central Garden & Pet's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Central Garden & Pet reported revenue of $490.46MM vs $413.41MM (up 18.64%) and basic earnings per share $0.09 vs -$0.11. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Central Garden & Pet reported revenue of $2,054.48MM vs $1,829.02MM (up 12.33%) and basic earnings per share $1.57 vs $0.91 (up 72.53%). Central Garden & Pet is expected to report earnings on February 1st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.12.
To read the full Central Garden & Pet Company (CENTA) report, download it here: http://Fundamental-Markets.com/register/?so=CENTA
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
